AIT partner with Perfinity to provide 10-minute protein analysis
The firms say the partnership – the first time the Perfinity Workstation has been installed in a contract research organisation (CRO) – will also cut sample preparation costs by between 30 and 50 per cent.
The tech is a closed system that integrates and automates the protein sample preparation process for mass spectrometry analysis.
It is now fully installed in AIT’s recently opened Indianapolis lab, as is ready to service pharma and biotech customers of both companies.
Steve Plump, CEO of Perfinity, told Outsourcing-Pharma: “The extraction, digestion and reverse phase workflow is automated with Perfinity software that delivers exceptional reproducibility, speed and cost per sample reduction when compared to current practices.”
AIT’s chairman Michael Evans added that the platform could help provide a solution to the “bottlenecked” protein analysis industry.
“The explosion of protein-based therapeutics and biomarkers has resulted in a development bottleneck in the analysis of these complex molecules,” said Evans.
“The Perfinity Workstation, combined with our mass spectrometry expertise… not only delivers speed but unprecedented quality.”
The system will also be used to identify differences between biosimilars and branded biologics.
To Perfinity and beyond
Perfinity, who first launched the platform this summer, is already working with several labs through the AIT alliance.
Plump told us: “AIT has already signed contacts with several pharmaceutical customers, and Perfinity has sold units to academic and proteomic laboratories.”
He added that the business is now on the hunt for proteomic lab, pharmaceutical, biotech, and biosimilar companies, for new partnerships.
